Does the media refer more to LFST or INNV?

In the previous week, InnovAge had 2 more articles in the media than LifeStance Health Group. MarketBeat recorded 5 mentions for InnovAge and 3 mentions for LifeStance Health Group. InnovAge's average media sentiment score of 0.97 beat LifeStance Health Group's score of 0.71 indicating that InnovAge is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LifeStance Health Group 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive InnovAge 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend INNV or CRVL?

InnovAge presently has a consensus price target of $10.50, indicating a potential upside of 15.64%. Given InnovAge's higher possible upside, equities research analysts plainly believe InnovAge is more favorable than CorVel. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score InnovAge 2 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.75 CorVel 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has stronger valuation & earnings, INNV or CRVL?

CorVel has lower revenue, but higher earnings than InnovAge. InnovAge is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio InnovAge $989.71M 1.25 -$2.54M -$0.02 N/A CorVel $958.53M 4.28 $110.34M $2.25 35.73

Is INNV or CRVL more profitable?

CorVel has a net margin of 11.72% compared to InnovAge's net margin of -0.26%. CorVel's return on equity of 29.92% beat InnovAge's return on equity. Company Net Margins Return on Equity Return on Assets InnovAge -0.26% -1.03% -0.47% CorVel 11.72% 29.92% 17.82%

Does the media refer more to INNV or CRVL?

In the previous week, InnovAge had 3 more articles in the media than CorVel. MarketBeat recorded 5 mentions for InnovAge and 2 mentions for CorVel. CorVel's average media sentiment score of 1.79 beat InnovAge's score of 0.97 indicating that CorVel is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InnovAge 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CorVel 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media prefer OPCH or INNV?

In the previous week, Option Care Health had 11 more articles in the media than InnovAge. MarketBeat recorded 16 mentions for Option Care Health and 5 mentions for InnovAge. InnovAge's average media sentiment score of 0.97 beat Option Care Health's score of 0.69 indicating that InnovAge is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Option Care Health 5 Very Positive mention(s) 5 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive InnovAge 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor INNV or AVAH?

In the previous week, InnovAge had 2 more articles in the media than Aveanna Healthcare. MarketBeat recorded 5 mentions for InnovAge and 3 mentions for Aveanna Healthcare. InnovAge's average media sentiment score of 0.97 beat Aveanna Healthcare's score of 0.77 indicating that InnovAge is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InnovAge 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Aveanna Healthcare 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer PRVA or INNV?

In the previous week, InnovAge had 3 more articles in the media than Privia Health Group. MarketBeat recorded 5 mentions for InnovAge and 2 mentions for Privia Health Group. InnovAge's average media sentiment score of 0.97 beat Privia Health Group's score of 0.86 indicating that InnovAge is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Privia Health Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive InnovAge 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

InnovAge (INNV) Competitors

$9.20 +0.18 (+1.94%)

As of 10:16 AM Eastern

Compare

INNV vs. LFST, CRVL, OPCH, AVAH, and PRVA

Should you buy InnovAge stock or one of its competitors? InnovAge's main competitors and comparable companies include LifeStance Health Group (LFST), CorVel (CRVL), Option Care Health (OPCH), Aveanna Healthcare (AVAH), and Privia Health Group (PRVA). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does InnovAge compare to LifeStance Health Group?

LifeStance Health Group (NASDAQ:LFST) and InnovAge (NASDAQ:INNV) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, media sentiment, profitability, institutional ownership, risk, dividends and earnings.

In the previous week, InnovAge had 2 more articles in the media than LifeStance Health Group. MarketBeat recorded 5 mentions for InnovAge and 3 mentions for LifeStance Health Group. InnovAge's average media sentiment score of 0.97 beat LifeStance Health Group's score of 0.71 indicating that InnovAge is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LifeStance Health Group	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
InnovAge	2 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

LifeStance Health Group has a net margin of 3.19% compared to InnovAge's net margin of -0.26%. LifeStance Health Group's return on equity of 3.39% beat InnovAge's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LifeStance Health Group	3.19%	3.39%	2.33%
InnovAge	-0.26%	-1.03%	-0.47%

85.5% of LifeStance Health Group shares are held by institutional investors. Comparatively, 12.3% of InnovAge shares are held by institutional investors. 3.5% of LifeStance Health Group shares are held by insiders. Comparatively, 1.0% of InnovAge shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

LifeStance Health Group has higher revenue and earnings than InnovAge. InnovAge is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LifeStance Health Group	$1.42B	3.36	$9.66M	$0.13	96.31
InnovAge	$989.71M	1.25	-$2.54M	-$0.02	N/A

LifeStance Health Group has a beta of 1.24, suggesting that its stock price is 24% more volatile than the broader market. Comparatively, InnovAge has a beta of 0.15, suggesting that its stock price is 85% less volatile than the broader market.

LifeStance Health Group presently has a consensus target price of $13.13, suggesting a potential upside of 4.83%. InnovAge has a consensus target price of $10.50, suggesting a potential upside of 15.64%. Given InnovAge's higher possible upside, analysts plainly believe InnovAge is more favorable than LifeStance Health Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LifeStance Health Group	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73
InnovAge	2 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.75

Summary

LifeStance Health Group beats InnovAge on 13 of the 16 factors compared between the two stocks.

How does InnovAge compare to CorVel?

InnovAge (NASDAQ:INNV) and CorVel (NASDAQ:CRVL) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, media sentiment, profitability, dividends and analyst recommendations.

In the previous week, InnovAge had 3 more articles in the media than CorVel. MarketBeat recorded 5 mentions for InnovAge and 2 mentions for CorVel. CorVel's average media sentiment score of 1.79 beat InnovAge's score of 0.97 indicating that CorVel is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InnovAge	2 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CorVel	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

12.3% of InnovAge shares are owned by institutional investors. Comparatively, 51.4% of CorVel shares are owned by institutional investors. 1.0% of InnovAge shares are owned by company insiders. Comparatively, 39.7% of CorVel shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

InnovAge presently has a consensus price target of $10.50, indicating a potential upside of 15.64%. Given InnovAge's higher possible upside, equities research analysts plainly believe InnovAge is more favorable than CorVel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InnovAge	2 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.75
CorVel	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

CorVel has a net margin of 11.72% compared to InnovAge's net margin of -0.26%. CorVel's return on equity of 29.92% beat InnovAge's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InnovAge	-0.26%	-1.03%	-0.47%
CorVel	11.72%	29.92%	17.82%

InnovAge has a beta of 0.15, meaning that its share price is 85% less volatile than the broader market. Comparatively, CorVel has a beta of 1.05, meaning that its share price is 5% more volatile than the broader market.

CorVel has lower revenue, but higher earnings than InnovAge. InnovAge is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InnovAge	$989.71M	1.25	-$2.54M	-$0.02	N/A
CorVel	$958.53M	4.28	$110.34M	$2.25	35.73

Summary

CorVel beats InnovAge on 11 of the 15 factors compared between the two stocks.

How does InnovAge compare to Option Care Health?

Option Care Health (NASDAQ:OPCH) and InnovAge (NASDAQ:INNV) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, media sentiment, profitability, institutional ownership, earnings and valuation.

Option Care Health currently has a consensus price target of $29.48, indicating a potential downside of 5.28%. InnovAge has a consensus price target of $10.50, indicating a potential upside of 15.64%. Given InnovAge's higher probable upside, analysts plainly believe InnovAge is more favorable than Option Care Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Option Care Health	0 Sell rating(s)	14 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.13
InnovAge	2 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.75

Option Care Health has higher revenue and earnings than InnovAge. InnovAge is trading at a lower price-to-earnings ratio than Option Care Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Option Care Health	$5.65B	0.83	$207.59M	$1.33	23.40
InnovAge	$989.71M	1.25	-$2.54M	-$0.02	N/A

In the previous week, Option Care Health had 11 more articles in the media than InnovAge. MarketBeat recorded 16 mentions for Option Care Health and 5 mentions for InnovAge. InnovAge's average media sentiment score of 0.97 beat Option Care Health's score of 0.69 indicating that InnovAge is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Option Care Health	5 Very Positive mention(s)	5 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
InnovAge	2 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

98.1% of Option Care Health shares are owned by institutional investors. Comparatively, 12.3% of InnovAge shares are owned by institutional investors. 1.7% of Option Care Health shares are owned by insiders. Comparatively, 1.0% of InnovAge shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Option Care Health has a beta of 0.58, meaning that its stock price is 42% less volatile than the broader market. Comparatively, InnovAge has a beta of 0.15, meaning that its stock price is 85% less volatile than the broader market.

Option Care Health has a net margin of 3.68% compared to InnovAge's net margin of -0.26%. Option Care Health's return on equity of 18.74% beat InnovAge's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Option Care Health	3.68%	18.74%	7.25%
InnovAge	-0.26%	-1.03%	-0.47%

Summary

Option Care Health beats InnovAge on 12 of the 15 factors compared between the two stocks.

How does InnovAge compare to Aveanna Healthcare?

InnovAge (NASDAQ:INNV) and Aveanna Healthcare (NASDAQ:AVAH) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, earnings, dividends, risk, analyst recommendations and institutional ownership.

Aveanna Healthcare has a net margin of 10.56% compared to InnovAge's net margin of -0.26%. Aveanna Healthcare's return on equity of 80.70% beat InnovAge's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InnovAge	-0.26%	-1.03%	-0.47%
Aveanna Healthcare	10.56%	80.70%	7.42%

InnovAge has a beta of 0.15, suggesting that its stock price is 85% less volatile than the broader market. Comparatively, Aveanna Healthcare has a beta of 1.95, suggesting that its stock price is 95% more volatile than the broader market.

12.3% of InnovAge shares are held by institutional investors. Comparatively, 88.0% of Aveanna Healthcare shares are held by institutional investors. 1.0% of InnovAge shares are held by insiders. Comparatively, 5.3% of Aveanna Healthcare shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

InnovAge presently has a consensus target price of $10.50, indicating a potential upside of 15.64%. Aveanna Healthcare has a consensus target price of $14.06, indicating a potential upside of 13.72%. Given InnovAge's higher possible upside, research analysts clearly believe InnovAge is more favorable than Aveanna Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InnovAge	2 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.75
Aveanna Healthcare	0 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.67

Aveanna Healthcare has higher revenue and earnings than InnovAge. InnovAge is trading at a lower price-to-earnings ratio than Aveanna Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InnovAge	$989.71M	1.25	-$2.54M	-$0.02	N/A
Aveanna Healthcare	$2.43B	1.11	$225.03M	$1.23	10.05

In the previous week, InnovAge had 2 more articles in the media than Aveanna Healthcare. MarketBeat recorded 5 mentions for InnovAge and 3 mentions for Aveanna Healthcare. InnovAge's average media sentiment score of 0.97 beat Aveanna Healthcare's score of 0.77 indicating that InnovAge is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InnovAge	2 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Aveanna Healthcare	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Aveanna Healthcare beats InnovAge on 12 of the 16 factors compared between the two stocks.

How does InnovAge compare to Privia Health Group?

Privia Health Group (NASDAQ:PRVA) and InnovAge (NASDAQ:INNV) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations.

Privia Health Group has a net margin of 1.19% compared to InnovAge's net margin of -0.26%. Privia Health Group's return on equity of 3.52% beat InnovAge's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Privia Health Group	1.19%	3.52%	2.00%
InnovAge	-0.26%	-1.03%	-0.47%

94.5% of Privia Health Group shares are owned by institutional investors. Comparatively, 12.3% of InnovAge shares are owned by institutional investors. 5.7% of Privia Health Group shares are owned by company insiders. Comparatively, 1.0% of InnovAge shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Privia Health Group has a beta of 0.8, indicating that its stock price is 20% less volatile than the broader market. Comparatively, InnovAge has a beta of 0.15, indicating that its stock price is 85% less volatile than the broader market.

Privia Health Group has higher revenue and earnings than InnovAge. InnovAge is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Privia Health Group	$2.12B	1.30	$22.92M	$0.21	103.19
InnovAge	$989.71M	1.25	-$2.54M	-$0.02	N/A

In the previous week, InnovAge had 3 more articles in the media than Privia Health Group. MarketBeat recorded 5 mentions for InnovAge and 2 mentions for Privia Health Group. InnovAge's average media sentiment score of 0.97 beat Privia Health Group's score of 0.86 indicating that InnovAge is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Privia Health Group	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
InnovAge	2 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Privia Health Group presently has a consensus target price of $31.00, suggesting a potential upside of 43.05%. InnovAge has a consensus target price of $10.50, suggesting a potential upside of 15.64%. Given Privia Health Group's stronger consensus rating and higher possible upside, equities research analysts plainly believe Privia Health Group is more favorable than InnovAge.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Privia Health Group	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79
InnovAge	2 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.75

Summary

Privia Health Group beats InnovAge on 13 of the 15 factors compared between the two stocks.

Get InnovAge News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding INNV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

INNV vs. The Competition

Export

Metric	InnovAge	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.25B	$10.41B	$7.43B	$12.75B
Dividend Yield	N/A	2.61%	2.52%	19.59%
P/E Ratio	-458.15	34.04	274.89	25.07
Price / Sales	1.27	4.67	568.47	74.22
Price / Cash	63.19	115.88	76.68	52.75
Price / Book	5.22	5.15	10.37	5.90
Net Income	-$2.54M	$315.68M	$3.49B	$380.43M
7 Day Performance	0.93%	0.05%	-3.10%	-4.14%
1 Month Performance	-15.80%	-4.23%	-7.39%	-6.70%
1 Year Performance	60.75%	9.59%	1.29%	-6.43%

InnovAge Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
INNV InnovAge	2.461 of 5 stars	$9.20 +1.9%	$10.50 +14.2%	+56.6%	$1.25B	$989.71M	N/A	2,500	Short Interest Increase
LFST LifeStance Health Group	3.4396 of 5 stars	$12.12 -0.8%	$13.13 +8.3%	+146.0%	$4.67B	$1.58B	93.24	10,961
CRVL CorVel	1.7262 of 5 stars	$75.83 -0.2%	N/A	+11.6%	$3.88B	$958.53M	33.70	5,239	Positive News
OPCH Option Care Health	2.9079 of 5 stars	$31.00 +32.6%	$29.54 -4.7%	+14.8%	$3.50B	$5.65B	23.31	8,266	Analyst Forecast High Trading Volume
AVAH Aveanna Healthcare	4.3497 of 5 stars	$12.22 -1.2%	$14.06 +15.0%	+32.6%	$2.70B	$2.43B	9.93	35,500	Analyst Upgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:INNV) was last updated on 10/15/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

InnovAge (INNV) Competitors

INNV vs. LFST, CRVL, OPCH, AVAH, and PRVA

How does InnovAge compare to LifeStance Health Group?

Summary

How does InnovAge compare to CorVel?

Summary

How does InnovAge compare to Option Care Health?

Summary

How does InnovAge compare to Aveanna Healthcare?

Summary

How does InnovAge compare to Privia Health Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

INNV vs. The Competition

InnovAge Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

InnovAge (INNV) Competitors

INNV vs. LFST, CRVL, OPCH, AVAH, and PRVA

How does InnovAge compare to LifeStance Health Group?

Does the media refer more to LFST or INNV?

Is LFST or INNV more profitable?

Do insiders & institutionals have more ownership in LFST or INNV?

Which has preferable earnings and valuation, LFST or INNV?

Which has more risk and volatility, LFST or INNV?

Do analysts rate LFST or INNV?

Summary

How does InnovAge compare to CorVel?

Does the media refer more to INNV or CRVL?

Do insiders and institutionals have more ownership in INNV or CRVL?

Do analysts recommend INNV or CRVL?

Is INNV or CRVL more profitable?

Which has more risk and volatility, INNV or CRVL?

Which has stronger valuation & earnings, INNV or CRVL?

Summary

How does InnovAge compare to Option Care Health?

Do analysts rate OPCH or INNV?

Which has preferable earnings & valuation, OPCH or INNV?

Does the media prefer OPCH or INNV?

Do insiders and institutionals believe in OPCH or INNV?

Which has more volatility and risk, OPCH or INNV?

Is OPCH or INNV more profitable?

Summary

How does InnovAge compare to Aveanna Healthcare?

Is INNV or AVAH more profitable?

Which has more risk and volatility, INNV or AVAH?

Do institutionals & insiders believe in INNV or AVAH?

Do analysts prefer INNV or AVAH?

Which has better earnings & valuation, INNV or AVAH?

Does the media favor INNV or AVAH?

Summary

How does InnovAge compare to Privia Health Group?

Is PRVA or INNV more profitable?

Do insiders and institutionals have more ownership in PRVA or INNV?

Which has more volatility & risk, PRVA or INNV?

Which has better valuation and earnings, PRVA or INNV?

Does the media prefer PRVA or INNV?

Do analysts prefer PRVA or INNV?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

INNV vs. The Competition

InnovAge Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools